Schizophrenia

The Clinical Neurobiology of the Hippocampus: An Integrative view

Volumn , Issue , 2012, Pages

  Falkai, Peter ^a   Gruber, Oliver ^a   Schmitt, Andrea ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Antipsychotics; Cognition; Gene expression; Hippocampus; MRI; Neurobiology; Schizophrenia

Indexed keywords

EID: 84920479992     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780199592388.003.0016     Document Type: Chapter

References (176)

1. Aberg, K., Saetre P., Lindhom E., et al. (2006). Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B Neuropsychiatr Genet, 141B(1), 84-90.
2. Abbott, C., and Bustillo, J. (2006). What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr Opin Psychiatry, 19(2), 135-9.
3. Achim, A. M., Bertrand, M. C., Sutton, H., et al. (2007). Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. Arch Gen Psychiatry, 64(9), 999-1014.
4. Altar, C. A., Jurata, L. W., Charles, V., et al. (2005). Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry, 58(2), 85-96.
5. Amaral, D., and Lavanex, P. (2007). Hippocampal neuroanatomy. In Andersen, P., Morris, R., Amaral, D., Bliss, T., and O'Keefe, J. (Eds.) The Hippocampus Book, pp. 37-114. Oxford: Oxford University Press.
6. Andlin-Sobocki, P., and Rossler, W. (2005). Cost of psychotic disorders in Europe. Eur J Neurol, 12(Suppl 1), 74-7.
7. Andreasen, N. C., Carpenter, W. T. Jr, Kane, J. M., et al. (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry, 162(3), 441-9.
8. Anton, E. S., Marchionni, M. A., Lee, K. F., and Rakic, P. (1997). Role of GGF/ neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development, 124(18), 3501-10.
9. Arnold, S. E., Franz, B. R., Gur, R. C., et al. (1995). Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry, 152, 738-48.
10. Balu, D. T. and Coyle, J. T. (2011). Neuroplasticity signalling pathways linked to the pathophysiology of schizophrenia. Neurosci Biobehav Rev, 35(3), 848-70.
11. Barr, A. M., Young, C. E., Phillips, A. G., and Honer, W. G. (2006). Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway. Int J Neuropsychopharmacol, 9(4), 457-63.
12. Bartzokis, G., Nuechterlein, K. H., Lu, P. H., et al. (2003). Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry, 53, 412-21.
13. Bendikov, I., Nadri, C., Amar, S., et al. (2007). A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res, 90, 41-51.
14. Benes, F. M. (1989). Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull, 15(4), 585-93.
15. Benes, F. M. (2010). Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology, 35(1), 239-57.
16. Benes, F. M., Kwok, E. W., Vincent, S. L., and Todtenkopf, M. S. (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry, 44, 88-97.
17. Blouin, J. L., Dombroski, B. A., Nath, S. K., et al. (1998). Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet, 20(1), 70-3.
18. Bogerts, B. (1997). The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull, 23, 423-35.
19. Bogerts, B., Falkai, P., Haupts, M., et al. (1990). Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res, 3, 295-301.
20. Bogerts, B., Lieberman, J. A., Ashtari, M., et al. (1993). Hippocampusamygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry, 33, 236-46.
21. Braff, D. L., Geyer, M. A., Light, G. A., et al. (2001). Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res, 49, 171-8.
22. Brandon, N. J., Millar, J. K., Korth, C., Sive, H., Singh, K. K., and Sawa, A. (2009). Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci, 29(41), 12768-75.
23. Bray, N. J., Preece, A., Williams, N. M., et al. (2005). Haplotypes at the dystrobrevib binding protein (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet, 14(14), 1947-54.
24. Breese, C. R., Freedman, R., and Leonard, S. S. (1995). Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res, 674, 82-90.
25. Brose, N (2008). Altered complexin expression in psychiatric and neurological disorders: cause or consequence? Mol Cells, 25(1), 7-19.
26. Buonanno, A., and Fischbach, G. D. (2001). Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol, 11(3), 287-96.
27. Cannon, T. D., Hennah, W., van Erp, T. G., et al. (2005). Association of DISC1/ TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short-and long-term memory. Arch Gen Psychiatry, 62(11), 1205-13.
28. Cannon, M., Jones, P. B., and Murray, R. M. (2002). Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry, 159(7), 1080-92.
29. Carlsson, A. (1995). The dopamine theory revisited. In Hirsch, S. R., and Weinberger, D. R. (Eds.) Schizophrenia, pp. 379-400. Oxford: Blackwell Science.
30. Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., and Carlsson, M. L. (2001). Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Ann Rev Pharmacol Toxikol, 41, 237-60.
31. Casanova, M. F., Stevens, J. R., and Kleinman, J. E. (1990). Astrocytosis in the molecular layer of the dentate gyrus: a study in Alzheimer's disease and schizophrenia. Psychiatry Res, 35, 149-66.
32. Chakos, M. H., Schobel, S. A., Gu, H., et al. (2005). Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br J Psychiatry, 186, 26-31.
33. Chambers, J. S., and Perrone-Bizzozero, N. I. (2004). Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem Res, 29, 2293-302.
34. Choi, D. W. (1992). Excitotoxic cell death. J Neurobiol, 23, 1261-76.
35. Chumakov, I., Blumenfeld, M., Guerassimenko, O., et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for Damino acid ocidase in schizophrenia. Proc Natl Acad Sci USA, 99, 13675-80.
36. Cirillo, M. A., and Seidman, L. J. (2003). Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev, 13(2), 43-77.
37. Conover, J. C., and Allen, R. L. (2002). The subventricular zone: new molecular and cellular developments. Cell Mol Life Sci, 59(12), 2128-35.
38. Corfas, G., Roy, K., and Buxbaum, J. D. (2004). Neuregulin 1-ErbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci, 7(6), 575-80.
39. Corvin, A., Donohoe, G., McGhee, K., et al. (2007). D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. Neurosci Lett, 426(2), 97-100.
40. Coyle, J. T. (1996). The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry, 3(5), 241-53.
41. Deakin, I. H., Law, A. J., Oliver, P. L., et al. (2009). Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport, 20(17), 1523-8.
42. Dean, B., Scarr, E., Bradbury, R., and Copolov, D. (1999). Decreased hippocampal (CA3) NMDA receptors in schizophrenia. Synapse, 32, 67-9.
43. Dracheva, S., Davis, K. L., Chin, B., Woo, D. A., Schmeidler, J., and Haroutunian, V. (2006). Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis, 21, 531-40.
44. Du, Y., and Dreyfus, C. F. (2002). Oligodendrocytes as providers of growth factors. J Neurosci Res, 68, 647-54.
45. Dwork, A. J. (1997). Postmortem studies of the hippocampal formation in schizophrenia. Schizophr Bull, 23, 385-402.
46. Eastwood, S. L., Brunet, P. W. J., and Harrison, P. J. (2000). Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse, 36, 167-77.
47. Eastwood, S. L., and Harrison, P. J. (2001). Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull, 55(5), 569-78.
48. Eastwood, S. L., Kerwin, R. W., and Harrison, P. J. (1997). Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiatry, 41, 636-43.
49. Ebner, F., Tepest, R., Dani, I., et al. (2008). The hippocampus in families with schizophrenia in relation to obstetric complications. Schizophr Res, 104(1-3), 71-8.
50. Falls, D. L. (2003). Neuregulins: functions, forms, and signaling strategies. Exp Cell Res, 284(1), 14-30.
51. Falkai, P., and Bogerts, B. (1986). Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci, 236, 154-61.
52. Falkai, P., Honer, W. G., David, S., et al. (1999). No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol, 25, 48-53.
53. Farber, N. B., Newcomer, J. W., and Olney, J. W (1999). Glycine agonists:what can they teach us about schizophrenia? Arch Gen Psychiatry, 56, 13-17.
54. Fatemi, S. H., Earle, J. A., Stary, J. M., Lee, S., and Sedgewick, J. (2001). Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport, 12(15), 3257-62.
55. Fatemi, S. H., Folsom, T. D., Reutiman, T. J., Huang, H., Oishi, K., and Mori, S. (2009). Prenatal viral infection of mice at E16 causes changes in gene expression in hippocampi of the offspring. Eur Neuropsychopharmacol, 19(9), 648-53.
56. Fendt, M., Lex, A., Falkai, P., Henn, F. A., and Schmitt, A. (2008). Behavioural alterations after postnatal hypoxia and effects of clozapine: implications for schizophrenia. Pharmacopsychiatry, 41 (4), 138-45.
57. Gao, X., Sakai, K., Roberts, R. C., Conley, R. R., Dean, B., and Tamminga, C. A. (2000). Ionotropic glutamate receptors and expression of N-methyl-Daspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry, 157, 1141-9.
58. Goff, D. C., and Coyle, J. T. (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry, 158(9), 1367-77.
59. Gruber, O., Falkai, P., Schneider-Axmann, T., Schwab, S. G., Wagner, M., and Maier, W. (2008). Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. J Psychiatr Res, 43(1), 1-6.
60. Gruber, O., Trost, S., Wobrock, T., et al. (2010a). Association of DISC1 genetic variation with intermediate phenotypes in neuroimaging: replication and further extension. Biol Psychiatry, 67(9), 163S.
61. Gruber, O., Trost, S., Wobrock, T., et al. (2010b). Association of schizophrenia susceptibility genes with intermediate phenotypes: new findings from genomic imaging. Schizophr Res, 117(2-3), S335-S336.
62. Gur, R. E., Keshavan, M. S., and Lawrie, S. M. (2007). Deconstructing psychosis with human brain imaging. Schizophr Bull, 33(4), 921-31.
63. Habl, G., Zink, M., Petroianu, G., et al. (2009). Increased D-amino acid oxidase (DAAO) expression in the bilateral hippocampus of schizophrenia patients: a post-mortem study. J Neural Transm, 116, 1657-65.
64. Haroutunian, V., Katsel, P., Dracheva, S., and Davis, K. L. (2006). The human homolog of the QKI gene affected in the severe dysmaleination 'quaking' mouse phenotype: downregulated in multiple brain regions in schizophrenia. Am J Psychiatry, 163(10), 1834-7.
65. Haroutunian, V., Katsel, P., Dracheva, S., Stewart, D. G., and Davis, K. L. (2007). Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int J Neuropsychopharmacol, 10, 565-73.
66. Harrison, P. J. (2004). The hippocampus in schizophrenia: a review of the neuropathological evidence and ist pathophysiological implications. Psychopharmacology, 174(1), 151-62.
67. Harrison, P. J., and Eastwood, S. L. (2001). Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus, 11, 508-19.
68. Harrison, P. J., and Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry, 10(1), 40-68.
69. Heckers, S. (2001). Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus, 11, 520-8.
70. Heckers, S., Heinsen, H., Geiger, B., et al. (1991). Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry, 48, 1002-8.
71. Henseler, I., Falkai, P., and Gruber, O. (2009). A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia. Eur J Neurosci, 2009, 30(4), 693-702.
72. Henseler, I., Falkai, P., and Gruber, O. (2010). Disturbed functional connectivity within networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. J Psychiatr Res, 44(6), 364-72.
73. Hsu, J. C., Zhang, Y., Takagi, N., et al. (1998). Decreased expression and functionality of NMDA receptor complexes persist in the CA1, but not in the dentate gyrus after transient cerebral ischemia. J Cereb Blood Flow Metab, 18, 768-75.
74. Hu, S., Ying, Z., Gomez-Pinilla, F., and Frautschy, S. A. (2009). Exercise can increase small heat shock proteins (sHSP) and pre-and post-synaptic proteins in the hippocampus. Brain Research, 1249, 191-201.
75. Hurlemann, R., Tepest, R., Maier, W., Falkai, P., and Vogeley, K. (2005). Intact hippocampal gray matter in schizophrenia as revealed by automatized image analysis postmortem. Anat Embryol (Berl), 210, 513-17.
76. Ioannidis, J. P., Ntzani, E. E., and Trikalinos, T. A. (2001). Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet, 29(3), 306-9.
77. International Schizophrenia Consortium, Purcell, S. M., Wray, N. R., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748-52.
78. Jessen, F., Scheef, L., Germershausen, L., et al. (2003). Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatry, 160, 1305-12.
79. Jones-Gotman, M., and Milner, B. (1978). Right temporal-lobe contribution to image mediated verbal learning. Neuropsychologia, 16, 61-71.
80. Kaifu, T., Nakahara, J., Inui, M., et al. (2003). Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest, 111(3), 323-32.
81. Kalus, P., Buri, C., Slotboom, J., et al (2004). Volumetry and diffusion tensor imaging of hippocampal subregions in schizophrenia. Neuroreport, 15, 867-71.
82. Kapoor, R., Lim, K. S., Cheng, A., Garrick, T., and Kapoor, V. (2006). Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). Brain Res, 1106(1), 205-10.
83. Katsel, P., Davis, K. L., and Haroutunian, V. (2005). Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res, 79, 157-73.
84. Kendler, K. S., MacLean, C. J., O'Neill, F. A., et al. (1996). Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish study of high-density schizophrenia families. Am J Psychiatry, 153(12), 1534-40.
85. Kerwin, R., Patel, S., and Meldrum, B. (1990). Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience, 39, 25-32.
86. Kircher, T., Thienel, R., Wagner, M., et al. (2009). Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci, 259(2), 72-9.
87. Knable, M. B., Barci, B. M., Webster, M. J., et al. (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry, 9(6), 609-20.
88. Kolomeets, N. S., Orlocskaya, D. D., Rachmanova, V. I., and Uranova, N. A. (2005). Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse, 57(1), 47-55.
89. Koolschijn, P. C., van Haren, N. E., Cahn, W., et al. (2010). Hippocampal volume change in schizophrenia. J Clin Psychiatry, 71(6), 737-44.
90. Kraepelin, E. (1919). Dementia praecox and paraphrenia. Edinburgh:Livingstone.
91. Kuroki, N., Kubicki, M., Nestor, P. G., et al (2006). Fornix integrity and hippocampal volume in male schizophrenic patients. Biol Psychiatry, 60, 22-31.
92. Lauriat, T. L., Shiue, K., Haroutunian, V., et al. (2008). Developmental expression profile of quaking, a candidate gene for schizophrenia, and its target genes in human prefrontal cortex and hippocampus shows regional specificity. J Neurosci Res, 86(4), 785-96.
93. Law, A. J., Lipska, B. K., Weickert, C. S., et al. (2006). Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci U S A, 103(17), 6747-52.
94. Lewis, C. M., Levinson, D. F., Wise, L. H., et al. (2003). Genome scan metaanalysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet, 73(1), 34-48.
95. Lim, K. O., Ardekani, B. A., Nierenberg, J., et al. (2006). Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. Am J Psychiatry, 163, 2008-10.
96. Lipska, B. K., Al-Amin, H. A., and Weinberger, D. R. (1998). Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology, 19, 451-64.
97. Lipska, B. K., Aultman, J. M., Verma, A., Weinberger, D. R., and Moghaddam, B. (2002). Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology, 27, 47-54.
98. Liu, X., Hea, G., Wanga, X., et al. (2004). Association of DAAO with schizophrenia in the Chinese population. Neuroscience Letters, 369, 228-33.
99. Liu, Y., Ford, B., Mann, M. A., and Fischbach, G. D. (2001). Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci, 21(15), 5660-9.
100. Martins-de-Souza, D., Dias-Neto, E., Schmitt, A., et al. (2010). Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry, 11(2), 110-20.
101. McInnes, L. A., and Lauriat, T. L. (2006). RNA metabolism and dysmyelination in schizophrenia. Neurosci Biobehav Rev, 30(4), 551-61.
102. Milner, B., Corkin, C., and Teuber, H. L. (1968). Further analysis of the hippocampal manestic syndrome: 14-year follow-up study of HM. Neuropsychologia, 6, 215-34.
103. Monyer, H., Burnashev, N., Laurie, DJ., et al. (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 12(3), 529-40.
104. Morikawa, E., Mori, H., Kiyama, Y., Mishina, M., Asano, T., and Kirino, T. (1998). Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor. J Neurosci, 18, 9727-32.
105. Mouton, P. R., Long, J. M., Lei, D. L., et al. (2002). Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res, 956, 30-5.
106. Nasrallah, H. A., Hopkins, T., and Pixley, S. K. (2010). Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats. Brain Res, 1354, 23-9.
107. Newton, S. S., and Duman, R. S. (2007). Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs, 21(9), 715-25.
108. O'Donovan, M. C., Craddock, N., Norton, N., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet, 40(9), 1053-5.
109. Olbrich, H. M., Valerius, G., Rüsch, N., et al. (2008). Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study. World J Biol Psychiatry, 9(1), 59-63.
110. Olney, J. W., and Farber, N. B. (1995). Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry, 52, 998-1007.
111. Ozaki, M., Sasner, M., Yano, R., Lu, H. S., and Buonanno, A. (1997). Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature, 390(6661), 691-4.
112. Pajonk, F., Wobrock, T., Gruber, O., et al. (2010). Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry, 67(2), 133-43.
113. Panenka, W. J., Khorram, B., Barr, A. M., et al. (2007). A longitudinal study on effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia. Schizophr Res, 94(1-3), 288-92.
114. Parlapani, E., Schmitt, A., Bergmann, A., et al. (2009). Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia. Brain Res, 1301, 126-34.
115. Parlapani, E., Schmitt, A., Wirths, O., et al. (2010). Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients. World Journal of Biol Psychiatry, 11, 243-50.
116. Pulver, A. E., Lasseter, V. K., Kasch, L., et al. (1995). Schizophrenia:a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet, 60(3), 252-60.
117. Rametti, G., Junque, C., Vendreil, P., et al. (2009). Hippocampal underactivation in an fMRI study of word and face memory recognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci, 259(4), 203-11.
118. Reif, A., Fritzen, S., Finger, M., et al. (2006). Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry, 11, 514-22.
119. Reske, M., Kellermann, T., Habel, U., et al. (2007). Stability of emotional dysfunctionsß A long-term fMRI study in first-episode schizophrenia. J Psychiatr Res, 41(11), 918-27.
120. Rieff, H. I., Raetzman, L.T., Sapp, D. W., Yeh, H. H., Siegel, R. E., and Corfas, G. (1999). Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci, 19(24), 10757-66.
121. Robinson, D. G., Woerner, M. G., Alvir, J. M., et al. (2002). Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res, 57(2-3), 209-19.
122. Roth, T. L., Lubin, F. D., Sodhi, M., et al. (2009). Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta, 1790(9), 869-77.
123. Rüsch, N., Taebartz van Elst, L., Valerius, G., et al. (2008). Neurochemical and structural correlates of executive dysfunction in schizophrenia. Schizophr Res, 99(1-3), 155-63.
124. Saha, S., Chant, D., and McGrath, J (2007). A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007, 64(10), 1123-31.
125. Sawada, K., Barr, A. M., Nakamura, M., et al. (2005). Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry, 62(3), 263-72.
126. Schell, M. J., Molliver, M. E., and Snyder, S. H. (1995). D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamatestimulated release. Proc Natl Acad Sci USA, 92, 3948-52.
127. Schmidt-Kastner, R., and Freund, T. F. (1991). Selective vulnerability of the hippocampus in brain ischemia. Neuroscience, 40, 599-636.
128. Schmitt, A., Zink, M., May, B., et al. (2003). Decreased gene expression of glial and neuronal glutamate transporters after antipsychotic treatment in rat brain. Neurosci Lett, 347(2), 81-4.
129. Schmitt, A., Zink, M., Müller, B., et al. (2003). Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits. Neurochem Res, 28(2), 235-41.
130. Schmitt, A., Weber, S., Jatzko, A., Braus, D. F., and Henn, F. A. (2004). Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment. J Neural Transm, 111 (1), 91-100.
131. Schmitt, A., Fendt, M., Zink, M., et al. (2007). Altered NMDA receptor expression and behaviour following postnatal hypoxia and its potential relevance to schizophrenia. J Neural Transm, 114 (2), 239-48.
132. Schmitt, A., Parlapani, E., Gruber, O., Wobrock, T., and Falkai, P. (2008). Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies. Eur Arch Psychiatry Clin Neurosci, 258(Suppl 5), 35-9.
133. Schmitt, A., Steyskal, C., Bernstein, H. G., et al. (2009). Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol, 117(4), 395-407.
134. Schumacher, J., Abon Jamra, R., Freudenberg, J., et al. (2004). Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry, 9, 203-7.
135. Segal, D., Koschnick, J. R., Slegers, L. H., and Hof, P. R. (2007). Oligodendrocyte pathophysiology: a new view of schizophrenia. Int J Neuropsychopharmacol, 10(4), 503-11.
136. Shenton, M. E., Dickey, C., Frumin, C., and McCarley, R. W. (2001). A review of MRI findings in schizophrenia. Schizophr Res, 49, 1-52.
137. Shih, R. A., Belmonte, P. L., and Zandi, P. P. (2004). A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry, 16(4), 260-83.
138. Smith, M. L., and Milner, B. (1981). The role of the right hippocampus in the recall of spatial location. Neuropsychologica, 19, 781-93.
139. Shirayama, Y., Obala, T., Matsuzawa, D., et al. (2010). Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. Neuroimage, 49(3), 2783-90.
140. Shukitt-Hale, B., Kadar, T., Marlowe, B. E., et al. (1996). Morphological alterations in the hippocampus following hypobaric hypoxia. Hum Exp Toxicol, 15, 312-19.
141. Smith, G. N., Lang, D. J., Kopala, L. C., Lapointe, J. S., Falkai, P., and Honer, W. G. (2003). Developmental abnormailities of the hippocampus in first-episode schizophrenia. Biol Psychiatry, 53(7), 555-61.
142. Sokolov, B. P. (1998). Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of 'neuroleptic-free' schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J Neurochem, 71, 2454-64.
143. Steen, R. G., Hamer, R. M., and Liebermen, J. A. (2005). Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology, 30(11), 1949-62.
144. Steen, R. G., Mull, C., McClure, R., Hamer, R. M., and Lieberman, J. A. (2006). Brain volume in first-episode schizophrenia: systematic review and metaanalysis of magnetic resonance imaging studies. Br J Psychiatry, 188, 510-18.
145. Stefansson, H., Ophoff, R. A., Steinberg, S., et al. (2009). Common variants conferring risk of schizophrenia. Nature, 460(7256), 744-7.
146. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet, 71(4), 877-92.
147. Steiner, J., Bernstein, H. G., Bielau, H., et al. (2008). S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: A morphometric study. J Psychiatr Res, 42, 868-76.
148. Strohmaier, J., Frank, J., Wendland, J. R., et al. (2010). A reappraisal of the association between dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of german ancestry. Schizophr Res, 118(1-3), 98-105.
149. Swerdlow, N. R., Hanlon, F. M., Henning, L., Kim, Y. K., Gaudet, I., and Halim, N. D. (2001). Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization. Brain Res, 898, 195-203.
150. Syroid, D. E., Maycox, P. R., Burrola, P. G., et al. (1996). Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci U S A, 93(17), 9229-34.
151. Takei, K., Yamasue, H., Abe, O., et al. (2008). Disrupted integrity of the fornix is associated with impaired memory organization in schizophrenia. Schizophr Res, 103(1-3), 52-61.
152. Tkachev, D., Mimmack, M. L., Ryan, M. M., et al. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet, 362(9386), 798-805.
153. Tudesco Die, S., Vaz, L. J., Mantoan, M. A., et al. (2010). Assessment of working memory in patients with mesial temporal lobe epilepsy associated with unilateral hippocampal sclerosis. Epilepsy Behav, 18(3), 223-8.
154. Uranova, N. A., Vostrikov, V. M., Vikhreva, O. V., et al. (2007). The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol, 10, 537-45.
155. van den Buuse, M. (2003). Deficient prepulse inhibition of acoustic startle in Hooded-Wistar rats compared with Sprague-Dawley rats. Clin Exp Pharmacol Physiol, 30, 254-61.
156. Velakoulis, D., Stuart, G. W., Wood, S. J., et al. (2001). Selective bilateral hippocampal volume loss in chronic schizophrenia. Biol Psychiatry, 50, 531-9.
157. Velakoulis, D., Wood, S.J., Wong, M. T., et al. (2006). Hippocampal and amygdale volumes according to psychosis stage and diagnosis. A magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry, 63(2), 139-49.
158. Walker, M. A., Highley, J. R., Esiri, M. M., et al. (2002). Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry, 159, 821-8.
159. Weickert, C. S., Rothmond, D. A., Hyde, T. M., Kleinman, J. E., and Straub, R. E. (2008). Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res, 98(1-3), 105-10.
160. Weinberger, D. R. (1996). On the plausibility of 'the neurodevelopmental hypothesis' of schizophrenia. Neuropsychopharmacology, 14(3 Suppl), 1S-11S.
161. Weinberger, D. R. (1999). Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry, 45, 395-402.
162. Weiss, A. P., and Heckers, S. (2001). Neuroimaging of declarative memory in schizophrenia. Scand J Psychol, 42, 239-50.
163. White, T., Kendi, A. T., Lehericy, S., et al. (2007). Disruption of hippocampal connectivity in children and adolescents with schizophrenia-a voxel-based diffusion tensor imaging study. Schizophr Res, 90, 302-7.
164. Williams, R. W., and Rakic, P. (1988). Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol, 278, 344-52.
165. Witter, M. P. (1993). Orgainzation of the entorhinal-hippocampal system: A review of the current anatomical data. Hippocampus, 3, 33-44.
166. Wood, L. S., Pickering, E. H., and Dechaio, B. M. (2007). Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol Psychiatry, 61(10), 1195-9.
167. Wood, S. J., Velakoulis, D., Smith, D. J., et al. (2001). A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res, 52(1-2), 37-46.
168. Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W., David, A. S., Murray, R. M., and Bullmore, E. T. (2000). Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry, 157, 16-25.
169. Yakovlev, P. I., and Lecours, A. R. (1967). The myelogenetic cycles of regional maturation of the brain, pp. 3-70. Oxford: Blackwell Scientific Publications.
170. Yang, J. Z., Si, T. M., Ruan, Y., et al. (2003). Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry, 8(7), 706-9.
171. Young, C. E., Arima, K., Xie, J., et al. (1998). SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex, 8(3), 261-8.
172. Zhang, J. P., Burdick, K. E., Lencz, T., and Malhotra, A. K. (2010). Metaanalysis of genetic variation in DTNBP1 and general cognitive ability. Biol Psychiatry, 688(12), 1126-33.
173. Zhang, L., Hsu, J. C., Takagi, N., Gurd, J. W., Wallace, M. C., and Eubanks, J. H. (1997). Transient global ischemia alters NMDA receptor expression in rat hippocampus: correlation with decreased immunoreactive protein levels of the NR2A/2B subunits, and an altered NMDA receptor functionality. J Neurochem, 69, 1983-94.
174. Zhang, Z. J., and Reynolds, G. P. (2002). A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res, 55, 1-10.
175. Zhou, Y., Shu, N., Liu, Y., et al. (2008). Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia. Schizophr Res, 100, 120-32.
176. Zola-Morgan, S., and Squire, L. R. (1993). Neuroanatomy of memory. Annu Rev Neurosci, 16, 547-64.